--- title: "Allarity Therapeutics (ALLR.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/ALLR.US/norm.md" symbol: "ALLR.US" name: "Allarity Therapeutics" parent: "https://longbridge.com/en/quote/ALLR.US.md" datetime: "2026-03-09T15:31:16.200Z" locales: - [en](https://longbridge.com/en/quote/ALLR.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/ALLR.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/ALLR.US/norm.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ALLR.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ALLR.US/norm.md) # Allarity Therapeutics (ALLR.US) — Financial Reports ## Income Statement (USD) | Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | EPS | -0.1904 | -0.1493 | -0.2451 | -1.72 | -7.71 | | ROE | -92.84% | -60.19% | -71.71% | -240.66% | -296.40% | | Revenue | - | - | - | - | - | | Net income | -2.81M | -2.32M | -2.73M | -7.45M | -12.15M | | Operating income | -2.52M | -4.13M | -3.04M | -7.32M | -2.61M | | Gross margin | - | - | - | - | - | | Net margin | - | - | - | - | - | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 20.80M | 21.20M | 29.73M | 22.65M | 20.38M | | Leverage | 1.73 | 1.74 | 1.59 | 1.92 | 1.57 | | BVPS | 0.7455 | 0.8322 | 1.10 | 1.62 | 4.70 | | Turnover | - | - | - | - | - | | Cash & STI | 16.89M | 17.80M | 25.20M | 19.61M | 18.46M | | Inv & Rec | - | - | - | - | - | | LT assets | 330000.00 | 322000.00 | 308000.00 | 309000.00 | 12000.00 | | Net debt | -15.51M | -16.43M | -23.84M | -18.25M | -17.13M | ## Cash Flow Statement (USD) | Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | -3.41M | -5.48M | -2.69M | -3.21M | -5.44M | | Investing CF | - | - | - | -298000.00 | - | | Financing CF | 2.31M | -2.56M | 11.14M | 4.24M | 4.87M | | Free CF | -2.24M | -3.30M | -3.02M | -1.89M | -4.65M | | OCF coverage | - | - | - | -1075.84% | - | | Repaid & issued | - | - | - | 0.0000 | 0.0000 | | CapEx | - | - | - | -298000.00 | - |